Upstream Natural Gas E&P Stocks Q2 Highlights: Antero Resources (NYSE:AR)

EQT AB agreed to acquire Qiagen for €9.6B, offering €46.50 per share, an 8.6% premium. Qiagen's board is expected to approve the deal. EQT AB's EQT XI fund has started charging management fees, with 10–15% of its target investments made. EQT X is 85–90% invested and remains in its commitment period.

Qiagen has agreed to a EUR10.8 billion takeover by private equity firm EQT. The deal values the company at the offered price. Qiagen is a publicly traded company on the NYSE.

EQT Private Equity proposed an all-cash takeover offer for QIAGEN. EQT XI plans to invest 10-15% of its €23B target fund. Details on price, terms, and approvals are pending.

Qiagen announced a €9.6B ($10.78B) acquisition by EQT, with a €46.50 ($52.22) per share offer, an 8.6% premium. The deal highlights private equity interest in the molecular testing sector, according to Reuters.

QIAGEN N.V. (QIA) agreed to a €46.50 per share all-cash takeover by EQT, valuing the company at about €10.8B EV. The deal requires 50%+1 share acceptance, EGM approvals, and regulatory clearances, with an expected closing in mid-2027, according to the company.

QIAGEN (QIA) accepted a €46.50 per share cash tender offer from EQT XI, a 40.3% premium over the July 8, 2026 close. The deal requires over 50% shareholder acceptance, shareholder votes, and regulatory approvals, with an expected mid-2027 closing. The boards unanimously support the agreement, according to the company.